Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

phosphoramide

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phosphoramides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Michael Addition Catalyzed by Chiral Secondary Amine Phosphoramide Using Fluorinated Silyl Enol Ethers: Formation of Quaternary Carbon Stereocenters.
A chiral secondary amine phosphoramide was developed and identified as a powerful catalyst for the Mukaiyama-Michael addition of… 
Highly Cited
2013
Highly Cited
2013
Synthesis and antibacterial activities of novel nanocomposite films of chitosan/phosphoramide/Fe3O4 NPs.
New nanocomposite films of chitosan/phosphoramide/1-5% Fe3O4 NPs were prepared. The Fe3O4 NPs were synthesized as core-shell NPs… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2011
Highly Cited
2011
Cinchona alkaloid-based phosphoramide catalyzed highly enantioselective Michael addition of unprotected 3-substituted oxindoles to nitroolefins
A newly developed cinchonidine-derived phosphoramide 6b, simple and easily available, was identified as a powerful catalyst for… 
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2009
Review
2009
Recent development and improvement for boron hydride-based catalytic asymmetric reduction of unsymmetrical ketones.
  • B. Cho
  • Chemical Society reviews
  • 2009
  • Corpus ID: 13349813
Catalytic asymmetric reduction of prochiral ketones with hydrides such as boranes and borohydrides is one of the simplest and the… 
  • figure 1
Highly Cited
2008
Highly Cited
2008
Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
The design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors to reduce the loss of ammonia… 
Highly Cited
2006
Highly Cited
2006
Chiral phosphoramide-catalyzed enantioselective addition of allylic trichlorosilanes to aldehydes. Preparative studies with bidentate phosphorus-based amides.
On the basis of the mechanistic insight that more than one Lewis basic moiety (phosphoramide) is involved in the rate- and… 
Review
2006
Review
2006
Chiral phosphoramide-catalyzed enantioselective addition of allylic trichlorosilanes to aldehydes. Preparative and mechanistic studies with monodentate phosphorus-based amides.
The addition of allylic trichlorosilanes to benzaldehyde promoted by chiral phosphoramides to give the enantioenriched… 
Review
1997
Review
1997
An Overview of Cyclophosphamide and Ifosfamide Pharmacology
Cyclophosphamide and ifosfamide are alkylating agents administered to treat malignant disease. They are prodrugs and require… 
Highly Cited
1988
Highly Cited
1988
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
A series of bifunctional alkylators were tested against the genotypically and phenotypically heterogeneous continuous human… 
  • figure 1
  • figure 3
  • table 1
  • table 2
  • figure 6
Highly Cited
1986
Highly Cited
1986
Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus.
Mouse and rat small intestinal cDNA libraries were screened for recombinants derived from mRNAs whose concentration changed… 
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE